Khashayarsha Khazaie

Prof. Khashayarsha Khazaie

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Iradj SobhaniIradj Sobhani
Iradj Sobhani
EBEmma Bergsten
Emma Bergsten
SCSéverine Couffin
Séverine Couffin
AAAurélien Amiot
Aurélien Amiot
BNBiba Nebbad
Biba Nebbad
PSPhilippe J. Sansonetti
Philippe J. Sansonetti
Sporadic colorectal cancer (CRC) is a result of complex interactions between the host and its environment. Environmental stressors act by causing host cell DNA alterations implicated in the onset of cancer. Here we investigate the stressor ability of CRC-associated gut dysbiosis as causal agent of host DNA alterations. The epigenetic nature of these alterations was investigated in humans and in mice. Germ-free mice receiving fecal samples from subjects with normal colonoscopy or from CRC patients were monitored for 7 or 14 wk. Aberrant crypt foci, luminal microbiota, and DNA alterations (colonic exome sequencing and methylation patterns) were monitored following human feces transfer. CRC-associated microbiota induced higher numbers of hypermethylated genes in murine colonic mucosa (vs. healthy controls’ microbiota recipients). Several gene promoters including SFRP1,2,3, PENK, NPY, ALX4, SEPT9, and WIF1 promoters were found hypermethylated in CRC but not in normal tissues or effluents from fecal donors. In a pilot study ( n = 266), the blood methylation levels of 3 genes ( Wif1 , PENK , and NPY ) were shown closely associated with CRC dysbiosis. In a validation study ( n = 1,000), the cumulative methylation index (CMI) of these genes was significantly higher in CRCs than in controls. Further, CMI appeared as an independent risk factor for CRC diagnosis as shown by multivariate analysis that included fecal immunochemical blood test. Consequently, fecal bacterial species in individuals with higher CMI in blood were identified by whole metagenomic analysis. Thus, CRC-related dysbiosis induces methylation of host genes, and corresponding CMIs together with associated bacteria are potential biomarkers for CRC.

16 February 2018 in Genes
Verified
Journal Article
Open access
PDF file
FBFaraz Bishehsari
Faraz Bishehsari
PEPhillip A Engen
Phillip A Engen
NPNailliw Z. Preite
Nailliw Z. Preite
Yunus Emre TunçilYunus Emre Tunçil
Yunus Emre Tunçil
ANAnkur Naqib
Ankur Naqib
AKAli Keshavarzian
Ali Keshavarzian
Epidemiological studies propose a protective role for dietary fiber in colon cancer (CRC). One possible mechanism of fiber is its fermentation property in the gut and ability to change microbiota composition and function. Here, we investigate the role of a dietary fiber mixture in polyposis and elucidate potential mechanisms using TS4Cre × cAPCl°x468 mice. Stool microbiota profiling was performed, while functional prediction was done using PICRUSt. Stool short-chain fatty acid (SCFA) metabolites were measured. Histone acetylation and expression of SCFA butyrate receptor were assessed. We found that SCFA-producing bacteria were lower in the polyposis mice, suggesting a decline in the fermentation product of dietary fibers with polyposis. Next, a high fiber diet was given to polyposis mice, which significantly increased SCFA-producing bacteria as well as SCFA levels. This was associated with an increase in SCFA butyrate receptor and a significant decrease in polyposis. In conclusion, we found polyposis to be associated with dysbiotic microbiota characterized by a decline in SCFA-producing bacteria, which was targetable by high fiber treatment, leading to an increase in SCFA levels and amelioration of polyposis. The prebiotic activity of fiber, promoting beneficial bacteria, could be the key mechanism for the protective effects of fiber on colon carcinogenesis. SCFA-promoting fermentable fibers are a promising dietary intervention to prevent CRC.

29 April 2022 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
FGFotini Gounari
Fotini Gounari
KKKhashayarsha Khazaie
Khashayarsha Khazaie

5 September 2017 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
MKMohammad W. Khan
Mohammad W. Khan
ASAbdulrahman Saadalla
Abdulrahman Saadalla
AEAhmed H. Ewida
Ahmed H. Ewida
KAKhalid Al-Katranji
Khalid Al-Katranji
GAGhadier Al-Saoudi
Ghadier Al-Saoudi
KKKhashayarsha Khazaie
Khashayarsha Khazaie

4 March 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
JQJasmin Quandt
Jasmin Quandt
SAStephen Arnovitz
Stephen Arnovitz
LHLeila Haghi
Leila Haghi
JWJanine Woehlk
Janine Woehlk
AMAzam Mohsin
Azam Mohsin
FGFotini Gounari
Fotini Gounari

12 August 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
AOAbu Osman
Abu Osman
BYBingyu Yan
Bingyu Yan
YLYing Li
Ying Li
KPKevin Daniel Pavelko
Kevin Daniel Pavelko
JQJasmine Quandt
Jasmine Quandt
KKKhashayarsha Khazaie
Khashayarsha Khazaie